Inserm Unit 1060/Inra 1235, University of Lyon, Lyon, France.
Clin Nutr. 2012 Aug;31(4):567-70. doi: 10.1016/j.clnu.2012.01.001. Epub 2012 Jan 28.
BACKGROUND & AIMS: Central venous catheter-associated bloodstream infection (CBSI) is a serious complication in patients on home parenteral nutrition (HPN). The aim was to analyze the impact of taurolidine-citrate lock solution (TLS) on CBSI rate in HPN patients with a high risk of catheter infection.
This retrospective study compared CBSI rates 12 months before and 12 months after implementation of TLS. In the first period, only standardized strategies were used to reduce the CBSI rate. In the second period, TLS was injected into the catheter at the end of parenteral nutrition. The CBSI rate with a confident interval was calculated as Poisson event rates, and compared by testing for homogeneity of rates.
15 patients were included. During the 24 months, the CBSI rate was 6.58/1000 catheter-days in the first period and 1.09/1000 catheter-days in the second period (p < 0.001). In patients with TLS once a week (n = 8), the CBSI rate decreased from 4.8/1000 catheter-days to 1.37/1000 catheter-days (p = 0.02) and in patients with TLS after each TPN (n = 7), the CBSI rate decreased from 8.61/1000 catheter-days to 0.78/1000 catheter-days (p = 0.001).
In HPN patients, TLS associated with standardized precautions significantly reduced the CBSI rate.
中心静脉导管相关性血流感染(CBSI)是接受家庭肠外营养(HPN)患者的严重并发症。本研究旨在分析牛磺罗定柠檬酸锁液(TLS)对具有导管感染高风险的 HPN 患者 CBSI 发生率的影响。
本回顾性研究比较了 TLS 实施前 12 个月和实施后 12 个月的 CBSI 发生率。在第一阶段,仅使用标准化策略来降低 CBSI 发生率。在第二阶段,TLS 在肠外营养结束时注入导管。CBSI 发生率以泊松事件发生率计算,并通过检验速率的同质性进行比较。
纳入 15 例患者。在 24 个月中,第一阶段 CBSI 发生率为 6.58/1000 导管日,第二阶段为 1.09/1000 导管日(p < 0.001)。每周使用 TLS 一次的患者(n = 8),CBSI 发生率从 4.8/1000 导管日降至 1.37/1000 导管日(p = 0.02);每次 TPN 后使用 TLS 的患者(n = 7),CBSI 发生率从 8.61/1000 导管日降至 0.78/1000 导管日(p = 0.001)。
在 HPN 患者中,TLS 联合标准化预防措施可显著降低 CBSI 发生率。